Cadrenal Therapeutics, Inc.

NASDAQ
CVKD
Stock
Yield per half year: -27.43%
Dividend yield: 0%
Sector: Healthcare

Reporting Cadrenal Therapeutics, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.001 0.0010 0.00
Чистая прибыль, млрд $
-0.0067 -0.0084 -0.0107 -0.0107 -0.0086 16.89
EV, млрд $
0.000608 -0.0012 0.0077 0.0077 0.0024 133.09
EBIT, млрд $
-0.0066 -0.0083 -0.0076 -0.0075 12.14
EBITDA, млрд $
-0.0066 -0.0083 -0.011 -0.011 -0.0086 18.56
OIBDA, млрд $
-0.0026 -0.0076 -0.0113 -0.0113 -0.0072 63.19
Баланс стоимость, млрд $
-0.0056 0.0077 0.0074 0.0074 0.0032 -209.74
FCF, млрд $
-0.0012 -0.0035 -0.0074 -0.0074 -0.0040 83.38
Операционный денежный поток, млрд $
-0.0012 -0.0035 -0.0074 -0.0074 -0.0040 83.38
Операционная прибыль, млрд $
-0.0027 -0.0076 -0.011 -0.011 -0.0071 59.71
Операционные расходы, млрд $
0.0027 0.0076 0.011 0.011 0.0071 59.71
CAPEX, млрд $
0 0 0 0


Balance sheet

IFRS
Reporting Annual Quarterly
2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0000 0.0084 0.01 0.01 0.0092 9.11
Total Receivables $
0.0000 0.0000
Total Current Assets $
0.000728 0.0085 0.0101 0.0101 0.0064 140.29
Чистые активы, млрд $
0.0000
Активы, млрд $
0.000778 0.0085 0.0101 0.0101 0.0065 135.02
Short Term Debt $
0.0001 0.0000 0.0000 0.0001 0.00
Long Term Debt $
0.000553 0.0006 0.00
Задолженность, млрд $
0.0063 0.000827 0.0027 0.0027 0.0033 -24.61
Чистый долг, млрд $
0.000608 -0.0084 -0.01 -0.01 -0.0059 -354.31
Долг, млрд $
0.000641 0.0000 0.0000 0.0006 0.00
Interest income $
0.000249 0.0002 0.00
Расходы на обслуживание долга $
0.000107 0.0000 0.0000 0.0001 0.00
Чист. проц. доходы, млрд $
0.000249 0.000249 0.0002 0.00
Амортизация, млрд $
0 0 0
Себестоимость, млрд $
0 0 0


Share

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -8.66 -9.63 -8.73 -8.73 -9.0067 0.27
Цена акции ао 11.1 14.49 13.86 13.86 13.15 7.68
Число акций ао, млн 0.7756 0.8682 1.22 1.22 0.9546 16.30
FCF/акцию -1.55 -4.07 -6.03 -6.03 -3.8833 57.28


Efficiency

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 120.95 -780.59 -140.78 -140.78 17.60 -266.8067 -205.19
ROA, % -862.83 -179.77 -114.27 -114.27 5.71 -385.6233 -49.03
ROS, % 0 0 0 0 13.36
ROCE, % 1187.7 -108.42 -102.6 -102.6 29.75 325.56 -144.21
Ebit margin, % 0 0
Рентаб EBITDA, % 0 0 26.54
Operation Margin, % 0 0 0 0 16.64
Доходность FCF, % -340.66 -340.6600 0.00


Coefficients

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-0.1241 64.95 -0.1241 0.00
P/BV
0.9311 2.38 2.38 8.15 1.66 59.88
P/FCF
0 0 0 0 8.97
E/P
-8.06 0 0 0 0.03 -8.0600 0.00
EV/EBIT
-0.092 0.1461 0.1597 -1 -1 -0.1966 81.57
EV/EBITDA
-0.0921 0.1462 -0.6983 -0.6983 51.61 -0.2147 96.45
EV/S
0 0 0 0 7.82
EV/FCF
-0.5048 0.3449 -1.04 -1.04 -1.04 17.74 -0.5600 19.81
Debt/EBITDA
-0.097 -0.0026 -0.0028 -0.0019 -0.0019 2.58 -0.0261 -62.59
Netdebt/Ebitda
-0.0921 1.01 0.914 0.914 0.914 0.46 0.6865 -277.49
Debt/Ratio
0.8233 0.0025 0.0025 0.0021 0.0021 0.24 0.2076 -77.53
Debt/Equity
-0.1154 0.0028 0 0.3608 0.3608 2.82 0.0827 -246.22
Debt/Net Income
-0.0954 -0.0026 -0.0026 -0.002 -0.002 10.75 -0.0257 -61.95
PEG
0 0
Бета
-0.7564 8.82 0.2564 0.2564 0.17 2.77 -169.73
Индекс Альтмана
0 -2.42 -3.63 -3.63 12.59 -3.0250 22.47


Dividends

IFRS
Reporting Annual Quarterly
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.71


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
3 4 15.47